LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

Net Margin
LAVA Therapeutics NV

-326.9%
Current
-497%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-326.9%
=
Net Income
-24.2m
/
Revenue
7.4m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
NL
LAVA Therapeutics NV
NASDAQ:LVTX
43.7m USD
-327%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
299.8B USD
9%
US
Amgen Inc
NASDAQ:AMGN
159.1B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
137.3B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34B EUR
-14%
Country NL
Market Cap 43.7m USD
Net Margin
-327%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 299.8B USD
Net Margin
9%
Country US
Market Cap 159.1B USD
Net Margin
13%
Country US
Market Cap 124.7B USD
Net Margin
-5%
Country US
Market Cap 114.8B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 86.2B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for LAVA Therapeutics NV.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-326.9%
=
Net Income
-24.2m
/
Revenue
7.4m
What is the Net Margin of LAVA Therapeutics NV?

Based on LAVA Therapeutics NV's most recent financial statements, the company has Net Margin of -326.9%.